A new winter season at Mills Observatory will begin with an interactive project demonstrating how the ‘C. elegans’, a minuscule worm that lives in your compost, helps world-leading research carried out at the University of Dundee.
CLS Impact and Outreach
The annual Life & Biomedical Sciences Education Student Awards Ceremony at the University of Dundee were held recently to recognise the accomplishments of dozens of high-achieving undergraduates.
51 students were congratulated for their hard work over the last academic year in LifeSpace Science Art Research Gallery, at the Wellcome Trust Biocentre, School of Life Sciences.
Last month Professor David Lilley from the School of Life Sciences was selected to chair a session at the prestigious Solvay Conference in Brussels. The Solvay Conferences began in 1911 and take place every three years in physics or chemistry. The event is invitation-only and attended by around 50 scientists who are the world leaders in the area of the meeting. The 1911 Solvay Conference in Physics was the first international conference in physics ever to be organised.
Scientists at the University of Dundee have identified a `molecular commando’ which can be stealthily deployed to activate a hypoxic response, a process which can help to fight a range of conditions including stroke, angina, colitis and brain injuries.
A Dundee team led by Professor Alessio Ciulli have used pioneering techniques to develop a `small molecule’ chemical probe called VH298, which offers highly targeted access to the parts of the cell which regulate hypoxia, known as the hypoxic signalling pathway.
A team of students from the University of Dundee and local school pupils have both won gold medals at this year’s iGEM Jamboree in Boston, USA.
Professor Fiona Powrie FRS from Kennedy Institute of Rheumatology, University of Oxford gave the Bridget Ogilvie Lecture 2016 yesterday with a talk entitled “Gut reactions: Immune pathways in the intestine in health and disease”. We were delighted that Dame Bridget Ogilvie was also in attendance.
A newly identified method of activating drugs to combat one of the world’s most destructive `neglected’ diseases could lead to better medicines according to new research led by the University of Dundee.
Visceral leishmaniasis (VL) is a disease which blights the developing world with 200,000 to 400,000 new cases and an estimated 40,000 deaths annually, making it the second biggest parasitic killer after malaria. The vast majority of cases are seen in seven countries - India, Nepal, Bangladesh, Brazil, Ethiopia, South Sudan and Sudan.
Today the SLS PhD Posters Session was held within the School. This session provided PhD students in their third year the opportunity to present their research to their fellow researchers. There were 38 students from across all the different departments taking part. The judges commented that again all the posters were of a very high standard but there could only be four prize winners.
The world renowned biomedical research which takes place at the University of Dundee has received a multi-million pound boost from Wellcome, the global charitable foundation.
Wellcome has awarded the University £3.75million from their Institutional Strategic Support Fund (ISSF), which enables universities in the UK and Ireland to invest in areas that are of mutual strategic importance to Wellcome and the individual institutions.
The ISSF grant will support biomedical research at Dundee, in particular helping fund: